Replies to post #244059 on Biotech Values

[swampboots]

AUTL and CAT-T ilk will in my opinion become more effective for larger players to mix and match, as new pathways are discovered which increase their platform's ultimate effectiveness by addressing the hidden "riffraff". Those obstacles which have stymied their drug cure platform targets. which may include turning on or off undiscovered proteins and influences which
interfere with the ideal primary routes customed targeted to be influenced toward a more effective controlled cure. Ha, each new middleman who adds a tweak (a fine adjustment) will add additional costs to the expensive treatments , but that is a matter to be resolved at another time.

[DewDiligence]

AUTL -33% on $172.5M* financing_at 33% discount to_yesterday’s_close:

https://finance.yahoo.com/news/autolus-announces-pricing-public-offering-021100226.html

*Assuming exercise of underwriter’s option.